Frequently Asked Questions for PAR-10-238, Ancillary Studies to the ACCORD Clinical Trial or the ACCORD Follow-on Study (R01)

Notice Number: NOT-HL-11-122

Key Dates
Release Date: October 8, 2010

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

On July 27, 2010, the NHLBI issued a Funding Opportunity Announcement (FOA): PAR-10-238 (Ancillary Studies to the ACCORD Clinical Trial or the ACCORD Follow-on Study [R01]) http://grants1.nih.gov/grants/guide/pa-files/PAR-10-238.html.

As a result of discussions with potential applicants, a list of Frequently Asked Questions (FAQs) has been developed.

The FAQs for this FOA can be found at: http://www.nhlbi.nih.gov/funding/inits/faq-PAR-10-238.htm. This information may be updated periodically without additional notice. NHLBI staff will also respond to questions submitted by potential applicants who contact the program, grants management, and review staff listed in the FOA in the Agency Contacts section.

Inquiries

Interested parties may contact:

Denise Bonds, MD, MPH
Division of Cardiovascular Sciences
National Heart, Lung and Blood Institute
National Institutes of Health
Rockledge Center 2, MDC 7936
6701 Rockledge Drive, Suite 10018
Bethesda, MD 20892-7936
EXPRESS/COURIER: Rockville, MD 20852
Phone: (301) 435-0379 Fax: (301) 480-1455
Email: Bondsde@nhlbi.nih.gov